Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Evidence-based guide to tirzepatide (Mounjaro) dosing considerations for Hispanic and Latino patients, covering pharmacogenomics, metabolic differences, clinical trial subgroup data, and practical titration guidance.
Read clinical reviewTirzepatide (Mounjaro) produces measurably different weight loss and glycemic outcomes in East Asian patients due to pharmacogenomic variation, lower BMI thresholds, and body-composition differences. This review covers ethnicity-stratified trial data, CYP variant frequencies, and dosing considerations.
Read clinical reviewEvidence-based guide to tirzepatide (Mounjaro) dosing considerations for East Asian patients, covering pharmacogenomics, BMI thresholds, trial subgroup data, and clinical monitoring.
Read clinical reviewA clinical deep-dive into tirzepatide (Mounjaro) efficacy differences in Hispanic and Latino patients, covering ethnicity-stratified RCT subgroup data, pharmacogenomics, insulin resistance phenotypes, and dosing considerations.
Read clinical reviewA clinical review of tirzepatide (Mounjaro) efficacy in Black and African ancestry patients, covering SURPASS trial subgroup data, pharmacogenomic factors, hypertension considerations, and evidence-based dosing guidance.
Read clinical reviewA clinical deep-dive into tirzepatide (Mounjaro) efficacy differences in South Asian patients: subgroup data, pharmacogenomics, BMI thresholds, and dosing considerations reviewed by the HealthRX.com medical team.
Read clinical review